Skip to main content
. Author manuscript; available in PMC: 2022 Nov 25.
Published in final edited form as: Lab Chip. 2021 Nov 25;21(23):4517–4548. doi: 10.1039/d1lc00627d

Figure 4. Overview of IVD’s that have received FDA EUA.

Figure 4.

A) Total number of IVD’s issued EUA by the FDA during previous declarations of the EUA pathway. Note: IVD’s that have had their EUA revoked are included in the analysis, and all listed pathogens here have current EUAs except H1N1 (designated with *). B) Breakdown of current SARS-CoV-2 IVDs that have received EUA by assay type (nucleic acid, antigen, antibody) and authorized setting to run the test. See ESI for more information on methods for data compilation.